Lena E. Friberg

10.0k total citations · 1 hit paper
215 papers, 6.8k citations indexed

About

Lena E. Friberg is a scholar working on Pharmacology, Oncology and Molecular Medicine. According to data from OpenAlex, Lena E. Friberg has authored 215 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pharmacology, 68 papers in Oncology and 65 papers in Molecular Medicine. Recurrent topics in Lena E. Friberg's work include Antibiotics Pharmacokinetics and Efficacy (81 papers), Antibiotic Resistance in Bacteria (65 papers) and Pneumonia and Respiratory Infections (25 papers). Lena E. Friberg is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (81 papers), Antibiotic Resistance in Bacteria (65 papers) and Pneumonia and Respiratory Infections (25 papers). Lena E. Friberg collaborates with scholars based in Sweden, United States and Netherlands. Lena E. Friberg's co-authors include Elisabet I. Nielsen, Mats O. Karlsson, Otto Cars, Matti Karvanen, Anja Henningsson, Hugo Maas, Laurent Nguyen, Geoffrey K. Isbister, Stephen B. Duffull and Diamantis Plachouras and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Lena E. Friberg

204 papers receiving 6.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics

2021 180 citations Elisabet I. Nielsen, Lena E. Friberg et al. Clinical Pharmacology & Therapeutics profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lena E. Friberg	2.6k	1.9k	1.8k	1.4k	1.1k	215	6.8k
Alexander A. Vinks	2.8k 1.1×	1.0k 0.5×	706 0.4×	1.7k 1.3×	678 0.6×	288	8.5k
Joseph Bertino	1.7k 0.7×	586 0.3×	1.3k 0.7×	1.2k 0.9×	791 0.7×	212	6.1k
Fritz Sörgel	1.8k 0.7×	767 0.4×	691 0.4×	1.3k 0.9×	1.0k 0.9×	144	5.4k
Roger W. Jelliffe	2.1k 0.8×	495 0.3×	507 0.3×	1.2k 0.9×	380 0.3×	148	5.0k
Charlotte Kloft	1.4k 0.6×	363 0.2×	650 0.4×	597 0.4×	749 0.7×	207	4.1k
Stephen B. Duffull	1.5k 0.6×	257 0.1×	512 0.3×	865 0.6×	921 0.8×	278	8.3k
Markus Zeitlinger	2.5k 1.0×	1.2k 0.6×	1.1k 0.6×	1.5k 1.1×	790 0.7×	340	6.9k
Ron A. A. Mathôt	1.3k 0.5×	209 0.1×	1.1k 0.6×	1.4k 1.0×	1.4k 1.2×	317	8.1k
Gary J. Kelloff	2.1k 0.8×	761 0.4×	2.8k 1.6×	532 0.4×	6.3k 5.6×	273	14.6k
Paul S. Lietman	2.5k 1.0×	837 0.4×	1.1k 0.6×	2.9k 2.1×	871 0.8×	161	8.1k

Countries citing papers authored by Lena E. Friberg

Since Specialization

Citations

This map shows the geographic impact of Lena E. Friberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lena E. Friberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lena E. Friberg more than expected).

Fields of papers citing papers by Lena E. Friberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lena E. Friberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lena E. Friberg. The network helps show where Lena E. Friberg may publish in the future.

Co-authorship network of co-authors of Lena E. Friberg

This figure shows the co-authorship network connecting the top 25 collaborators of Lena E. Friberg. A scholar is included among the top collaborators of Lena E. Friberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lena E. Friberg. Lena E. Friberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lundberg, Carina Vingsbo, et al.. (2025). Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus: from in vitro time–kill experiments to a mouse pneumonia model. Journal of Antimicrobial Chemotherapy. 80(7). 1860–1868. 1 indexed citations

Centanni, Maddalena, et al.. (2024). Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to children. Cancer Chemotherapy and Pharmacology. 94(2). 297–310. 1 indexed citations

Veerman, G., J. G. Coen van Hasselt, Hendrikus J. Dubbink, et al.. (2024). Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib. CPT Pharmacometrics & Systems Pharmacology. 13(4). 612–623. 4 indexed citations

Centanni, Maddalena, et al.. (2024). Pharmacogenetic Testing or Therapeutic Drug Monitoring: A Quantitative Framework. Clinical Pharmacokinetics. 63(6). 871–884. 2 indexed citations

Krishnan, Sreenath M., Lena E. Friberg, François Mercier, et al.. (2023). Multistate Pharmacometric Model to Define the Impact of Second‐Line Immunotherapies on the Survival Outcome of the IMpower131 Study. Clinical Pharmacology & Therapeutics. 113(4). 851–858. 8 indexed citations

Olsson, Anna, Chenyan Zhao, Lena E. Friberg, et al.. (2023). Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time–kill experiments: agreement with in silico predictions. Journal of Antimicrobial Chemotherapy. 79(2). 391–402. 5 indexed citations

Centanni, Maddalena, Abel Thijs, Ingrid M.E. Desar, Mats O. Karlsson, & Lena E. Friberg. (2022). Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors. Clinical and Translational Science. 16(1). 73–84. 3 indexed citations

Zhao, Chenyan, et al.. (2022). Population pharmacokinetics of apramycin from first-in-human plasma and urine data to support prediction of efficacious dose. Journal of Antimicrobial Chemotherapy. 77(10). 2718–2728. 20 indexed citations

Tängdén, Thomas, Carina Vingsbo Lundberg, Lena E. Friberg, & Angela Huttner. (2020). How preclinical infection models help define antibiotic doses in the clinic. International Journal of Antimicrobial Agents. 56(2). 106008–106008. 22 indexed citations

10.

Tano, Eva, Markus Castegren, Miklós Lipcsey, et al.. (2019). A non-linear mixed effect model for innate immune response: In vivo kinetics of endotoxin and its induction of the cytokines tumor necrosis factor alpha and interleukin-6. PLoS ONE. 14(2). e0211981–e0211981. 17 indexed citations

11.

Karlsson, Mats O., et al.. (2017). The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling. British Journal of Clinical Pharmacology. 84(3). 490–500. 11 indexed citations

12.

Nielsen, Elisabet I., et al.. (2017). Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring. Cancer Chemotherapy and Pharmacology. 80(2). 343–353. 16 indexed citations

13.

Sadiq, Muhammad Waqas, Elisabet I. Nielsen, Jean‐Marie Conil, et al.. (2016). A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection. Journal of Pharmacokinetics and Pharmacodynamics. 44(2). 69–79. 39 indexed citations

14.

Graan, Anne‐Joy M. de, Laure Elens, Jason A. Sprowl, et al.. (2013). CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity. Clinical Cancer Research. 19(12). 3316–3324. 91 indexed citations

15.

Eechoute, Karel, Martin N. Fransson, Floris A. de Jong, et al.. (2012). A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients. Clinical Cancer Research. 18(20). 5780–5787. 87 indexed citations

16.

Graan, Anne‐Joy M. de, Cynthia S. Lancaster, Amanda Obaidat, et al.. (2012). Influence of Polymorphic OATP1B-Type Carriers on the Disposition of Docetaxel. Clinical Cancer Research. 18(16). 4433–4440. 76 indexed citations

17.

Graan, Anne‐Joy M. de, Walter J. Loos, Lena E. Friberg, et al.. (2012). Influence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane Therapy. Clinical Cancer Research. 18(16). 4425–4432. 29 indexed citations

18.

Bol, Jessica M. van der, Ron H.J. Mathijssen, Geert-Jan Creemers, et al.. (2010). A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan. Clinical Cancer Research. 16(2). 736–742. 50 indexed citations

19.

Friberg, Lena E., C. Dansirikul, & Stephen B. Duffull. (2004). Simultaneous fit of competing models as a model discrimination tool in Bayesian analysis. Queensland's institutional digital repository (The University of Queensland). 3 indexed citations

20.

Fowler, Bruce A., Lena E. Friberg, Arne Jernelöv, et al.. (1978). Factors Influencing Metabolism and Toxicity of Metals: A Consensus Report. Environmental Health Perspectives. 25. 3–3. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact